Update on targeted agents for adjuvant treatment of colon cancer in 2006. - Wikidata - wikimedia - TriplyDB

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

http://www.wikidata.org/entity/Q37153311

about

Use of a computerised decision aid (DA) to inform the decision process on adjuvant chemotherapy in patients with stage II colorectal cancer: development and preliminary evaluation.

P2860

Q37728416-3EE3AED6-5998-42D7-8D16-91A2FF4547D8

P2860

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

http://www.wikidata.org/entity/Q37153311

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

@en

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

@nl

type

label

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

@en

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

@nl

prefLabel

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

@en

Update on targeted agents for adjuvant treatment of colon cancer in 2006.

@nl

P1433

Q37153311-919B13CC-8696-4018-B162-C06A6B6445E4

P1476

Q37153311-48840938-6190-4409-929A-7C84650AF8E7

P2093

Q37153311-160703CC-9D30-45A3-9BFB-DC2A76F973E8

Q37153311-2D2E2C2F-4B1F-42F3-96F2-40163F0B9CB1

Q37153311-35625E71-576E-413D-A39E-B0C33FE490B4

Q37153311-B9AC92D3-9CCB-4E41-89FD-271E555D711C

Q37153311-E778BBAF-4167-41F7-B4FF-92D1B70E10DD

P2860

Q37153311-01B1E2AD-9111-4949-8564-D1C3A522FE65

Q37153311-1EBF1CDA-EF02-41A7-B69F-8A882CE33D32

Q37153311-2C46D91C-E963-4C15-81F8-3E28F25D0165

Q37153311-38682694-4132-4BB4-AEBD-0B620B20A22F

Q37153311-7900D0DF-6963-40E1-9E84-36B77510AD2C

Q37153311-97CBED6B-EF34-4A4F-ABB3-5C7139734CC0

Q37153311-AA7BDDA5-BBAD-4B1A-B3C1-53F5BF49DB1C

Q37153311-B96A8859-57F7-4957-B1EC-9D8514DB28A9

Q37153311-C3582CE5-76F4-4130-A3F6-59384A9BEF49

Q37153311-CF3EB274-CD00-48E9-AC27-A77835A11F98

P304

Q37153311-53D92793-0E5B-461E-B7C7-2CBFF7F37243

P31

Q37153311-D5AC2139-914F-4815-9CC7-F25BC95A12B1

P433

Q37153311-B3F8A44B-C535-460C-8FCE-97BEB11F51F9

P478

Q37153311-6A76531F-552B-4BB4-9CEB-B28536FA84D4

P50

Q37153311-FE3DE85C-EC54-48DF-94D5-649438D692F3

P577

Q37153311-474D05E9-1B54-4FA1-9D00-E10C4E439A86

P698

Q37153311-4A0E4259-16DE-42B7-99BF-C41C123BC559

P932

Q37153311-4819307B-2AB7-4441-BC18-A49F7F3B93D2

P1433

Gastrointestinal cancer research : GCR

P1476

Update on targeted agents for adjuvant treatment of colon cancer in 2006

@en

P2093

Aimery de Gramont

http://www.w3.org/2001/XMLSchema#string

Annette K Larsen

http://www.w3.org/2001/XMLSchema#string

Christophe Louvet

http://www.w3.org/2001/XMLSchema#string

Christophe Tournigand

http://www.w3.org/2001/XMLSchema#string

GERCOR (French Oncology Research Group)

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis

Capecitabine as adjuvant treatment for stage III colon cancer.

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

P304

S47-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19360148

http://www.w3.org/2001/XMLSchema#string

P932

2666841

http://www.w3.org/2001/XMLSchema#string